Cano-Ortiz, ALeiva-Gea, IVentosa, A SGonzalez-Cruces, TSanchez-Gonzalez, J-MMorales, PVillarrubia, A2023-05-032023-05-032022-04-11Cano-Ortiz A, Leiva-Gea I, Ventosa ÁS, González-Cruces T, Sánchez-González JM, Morales P, et al. Stromal interstitial keratitis in a patient with COVID-19. J Fr Ophtalmol. 2022 Apr;45(4):e175-e177http://hdl.handle.net/10668/22305Since the outbreak of coronavirus disease 2019 (COVID19) in December 2019, the number of infections and deaths has increased exponentially. In February 2020, Lu et al. suggested that the ocular surface could be a route of transmission for severe acute respiratory syndrome coronavirus—2 (SARS-CoV-2), and studies were initiated on the association between the virus and the ocular surface[1]. Zhou et al. demonstrated the presence of SARS-CoV-2 in the conjunctival sac of patients with COVID19[2]. In addition, Chen et al. reported an association between conjunctival congestion, the main eye symptom associated with COVID-19, and conjunctivitis, which suggests that SARS-CoV-2 can cause conjunctivitis[3]. Daruich et al. [4] demonstrated that conjunctivitis can be the inaugural manifestation of the COVID-19 infection and their case report illustrates the interest of telemedicine in ophthalmology during the COVID-19 pandemic.enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Stromal interstitialKeratitisOphthalmologyVirusesSevere acute respiratory syndrome-related coronavirusCOVID-19Corneal StromaHumansKeratitisKeratitis, Herpeticresearch article35033376open accessInfeccionesCoronavirus relacionado al Síndrome Respiratorio Agudo SeveroInforme de investigaciónOftalmologíaTelemedicina10.1016/j.jfo.2021.11.0041773-0597PMC8733277https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733277https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733277/pdf